Science Explorer Back to mapMap

Most cited papers from Kissei Pharmaceutical (Japan)

What are the most cited papers from Kissei Pharmaceutical (Japan)?

The most cited paper from Kissei Pharmaceutical (Japan) is "Execution of Apoptosis Signal-regulating Kinase 1 (ASK1)-induced Apoptosis by the Mitochondria-dependent Caspase Activation" (Takiko Hatai, Atsushi Matsuzawa, Seiji Inoshita et al., 2000), with 334 citations. Next come "Advanced Glycation End Products-driven Angiogenesis in Vitro" (276) and "Intramolecular Nonbonded S···O Interaction Recognized in (Acylimino)thiadiazoline Derivatives as Angiotensin II Receptor Antagonists and Related Compounds" (271).

Showing 50 of 59 papers. Every paper with more than 76 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Execution of Apoptosis Signal-regulating Kinase 1 (ASK1)-induced Apoptosis by the Mitochondria-dependent Caspase Activation Takiko Hatai, Atsushi Matsuzawa, Seiji Inoshita et al. · Journal of Biological Chemistry Open access Aug 2000 334
2 Advanced Glycation End Products-driven Angiogenesis in Vitro Sho‐ichi Yamagishi, Hideto Yonekura, Yasuhiko Yamamoto et al. · Journal of Biological Chemistry Open access Mar 1997 276
3 Intramolecular Nonbonded S···O Interaction Recognized in (Acylimino)thiadiazoline Derivatives as Angiotensin II Receptor Antagonists and Related Compounds Yoshimitsu Nagao, Terukage Hirata, Satoru Goto et al. · Journal of the American Chemical Society 20 Mar 1998 271
4 Sergliflozin, a Novel Selective Inhibitor of Low-Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level Kenji Katsuno, Yoshikazu Fujimori, Yukiko Takemura et al. · Journal of Pharmacology and Experimental Therapeutics 18 Oct 2006 267
5 Physiological Roles of ASK1-Mediated Signal Transduction in Oxidative Stress- and Endoplasmic Reticulum Stress-Induced Apoptosis: Advanced Findings from ASK1 Knockout Mice Atsushi Matsuzawa, Hideki Nishitoh, Kei Tobiume et al. · Antioxidants and Redox Signaling Jun 2002 252
6 Costimulation through B7-2 (CD86) Is Required for the Induction of a Lung Mucosal T Helper Cell 2 (TH2) Immune Response and Altered Airway Responsiveness Shogo Tsuyuki, Junko Tsuyuki, Karin Einsle et al. · The Journal of Experimental Medicine Open access 5 May 1997 251
7 Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARδ agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet Tatsuya Nagasawa, Yoichi Inada, Shigeru Nakano et al. · European Journal of Pharmacology Mar 2006 235
8 Functional and molecular biological evidence for a possible β3‐adrenoceptor in the human detrusor muscle Yasuhiko Igawa, Yoshinobu Yamazaki, Hiroo Takeda et al. · British Journal of Pharmacology Open access Feb 1999 229
9 Regulation of Interleukin-1β-induced Interleukin-6 Gene Expression in Human Fibroblast-like Synoviocytes by p38 Mitogen-activated Protein Kinase Keiji Miyazawa, Akio Mori, Hiroshi Miyata et al. · Journal of Biological Chemistry Open access Sep 1998 225
10 Remogliflozin Etabonate, in a Novel Category of Selective Low-Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors, Exhibits Antidiabetic Efficacy in Rodent Models Yoshikazu Fujimori, Kenji Katsuno, Ikumi Nakashima et al. · Journal of Pharmacology and Experimental Therapeutics 26 Jun 2008 221
11 Mouse Model of Airway Remodeling Kazuhiko Shinagawa, Masami Kojima · American Journal of Respiratory and Critical Care Medicine 14 Jul 2003 213
12 PHARMACOLOGICAL PROPERTIES OF N‐(3′,4′‐DIMETHOXYCINNAMOYL) ANTHRANILIC ACID (N‐5′), A NEW ANTI‐ATOPIC AGENT Hiroshi Azuma, Kazuhide Banno, Toshihiro Yoshimura · British Journal of Pharmacology Open access Dec 1976 209
13 SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose Shigeki Tazawa, Tokuhisa Yamato, Hideki Fujikura et al. · Life Sciences 12 Nov 2004 208
14 Efficacy and safety of ustekinumab in Japanese patients with moderate‐to‐severe plaque‐type psoriasis: Long‐term results from a phase 2/3 clinical trial Atsuyuki Igarashi, Takeshi Kato, Mai Kato et al. · The Journal of Dermatology Open access 29 Sep 2011 206
15 The Mechanism Involved in the Inhibitory Action of Tranilast on Collagen Biosynthesis of Keloid Fibroblasts. Haruo SUZAWA, Shinji Kikuchi, Nobuhiko Arai et al. · The Japanese Journal of Pharmacology Open access 1992 200
16 Molecular Mechanisms of the Decision between Life and Death: Regulation of Apoptosis by Apoptosis Signal-Regulating Kinase 1 Atsushi Matsuzawa, Hidenori Ichijo · The Journal of Biochemistry Jul 2001 173
17 Sphingosine 1‐phosphate/sphingosine 1‐phosphate receptor 1 signaling in rheumatoid synovium: Regulation of synovial proliferation and inflammatory gene expression Masayasu Kitano, Timothy Hla, Masahiro Sekiguchi et al. · Arthritis & Rheumatism 28 Feb 2006 166
18 Physicochemical and Functional Properties of Buckwheat Protein Product Hiroyuki Tomotake, Iwao Shimaoka, Jun Kayashita et al. · Journal of Agricultural and Food Chemistry 28 Feb 2002 165
19 Consumption of Buckwheat Protein Lowers Plasma Cholesterol and Raises Fecal Neutral Sterols in Cholesterol-Fed Rats Because of Its Low Digestibility Jun Kayashita, Iwao Shimaoka, Misao Nakajoh et al. · Journal of Nutrition Open access Jul 1997 149
20 anti-Selective Catalytic Asymmetric Nitroaldol Reaction via a Heterobimetallic Heterogeneous Catalyst Tatsuya Nitabaru, Akihiro Nojiri, Makoto Kobayashi et al. · Journal of the American Chemical Society 9 Sep 2009 147
21 A Buckwheat Protein Product Suppresses Gallstone Formation and Plasma Cholesterol More Strongly than Soy Protein Isolate in Hamsters Iwao Shimaoka, Hiroyuki Tomotake, Jun Kayashita et al. · Journal of Nutrition Open access Jul 2000 146
22 ASK1 and ASK2 differentially regulate the counteracting roles of apoptosis and inflammation in tumorigenesis Takayuki Iriyama et al. · The EMBO Journal Open access 12 Feb 2009 129
23 Inhibitory Action of Tranilast, an Anti-Allergic Drug, on the Release of Cytokines and PGE2 from Human Monocytes-Macrophages. Haruo SUZAWA, Shinji Kikuchi, Kiyoshi Ichikawa et al. · The Japanese Journal of Pharmacology Open access 1992 128
24 Establishment and Characterization of a Novel Human Rheumatoid Fibroblast-Like Synoviocyte Line, MH7A, Immortalized with SV40 T Antigen Keiji Miyazawa, Akio Mori, Hirokazu Okudaira · The Journal of Biochemistry Dec 1998 126
25 Reduced phototoxicity of a fluoroquinolone antibacterial agent with a methoxy group at the 8 position in mice irradiated with long-wavelength UV light Kiyoshi Marutani, Marissa L. Matsumoto, Yoshiki Katsumi Osamu Otabe et al. · Antimicrobial Agents and Chemotherapy Open access Oct 1993 119
26 Evaluation of the rodent micronucleus assay by a 28‐day treatment protocol: Summary of the 13th Collaborative Study by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Environmental Mutagen Society of Japan (JEMS)–Mammalian Mutagenicity Study Group (MMS) Shuichi Hamada et al. · Environmental and Molecular Mutagenesis 2001 118
27 Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease Yoshitaka Hashimoto, Masahide Hamaguchi, Takao Kojima et al. · Medicine Open access May 2017 117
28 Rationale and Evidence for the Use of Oxcarbazepine in Neuropathic Pain Enrique J. Carrazana, Imao Mikoshiba · Journal of Pain and Symptom Management Open access 23 Apr 2003 115
29 Fibrate and Statin Synergistically Increase the Transcriptional Activities of PPARα/RXRα and Decrease the Transactivation of NFκB Ikuo Inoue, Fumiaki Itoh, Shigemi Aoyagi et al. · Biochemical and Biophysical Research Communications 2002 114
30 Inhibition of PDGF- and TGF-β1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats Keiji Miyazawa, Shinji Kikuchi, Juichi Fukuyama et al. · Atherosclerosis Dec 1995 108
31 Species differences in the distribution of β‐adrenoceptor subtypes in bladder smooth muscle Yoshinobu Yamazaki, Hiroo Takeda, Masuo Akahane et al. · British Journal of Pharmacology Open access Jun 1998 106
32 SGLT2 inhibitors: molecular design and potential differences in effect Masayuki Isaji · Kidney International Open access Mar 2011 105
33 Effect of database profile variation on drug safety assessment: an analysis of spontaneous adverse event reports of Japanese cases Kaori Nomura, Yasushi Hinomura, Genta Kawaguchi et al. · Drug Design Development and Therapy Open access Jun 2015 104
34 Effects of thromboxane synthetase inhibitors on aggregation of rabbit platelets Jun Naito, Hidetada Komatsu, Arao Ujiie et al. · European Journal of Pharmacology Jul 1983 101
35 Algorithm for sleep scoring in experimental animals based on fast Fourier transform power spectrum analysis of the electroencephalogram Sayaka Kohtoh, Yujiro Taguchi, Naomi Matsumoto et al. · Sleep and Biological Rhythms Jul 2008 100
36 Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo Masayuki Isaji, Hiroshi Miyata, Yoshiyuki Ajisawa et al. · British Journal of Pharmacology Open access Nov 1997 100
37 RELAXANT EFFECTS OF ISOPROTERENOL AND SELECTIVE β3-ADRENOCEPTOR AGONISTS ON NORMAL, LOW COMPLIANT AND HYPERREFLEXIC HUMAN BLADDERS Yasuhiko Igawa, Yoshinobu Yamazaki, Hiroo Takeda et al. · The Journal of Urology 2001 99
38 The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection Tsen‐Fang Tsai, Vincent C. Ho, Michael W. Song et al. · British Journal of Dermatology 14 Jul 2012 96
39 Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interaction Kinji Iizuka, Tetsuhide Kamijo, Hiromu Harada et al. · Journal of Medicinal Chemistry Open access Oct 1990 92
40 Hypocholesterolemic effect of buckwheat protein extract in rats fed cholesterol enriched diets Jun Kayashita, Iwao Shimaoka, Misao Nakajyoh · Nutrition Research May 1995 91
41 CXCR3 Binding Chemokine and TNFSF14 Over Expression in Bladder Urothelium of Patients With Ulcerative Interstitial Cystitis Teruyuki Ogawa, Toshiki Homma, Yasuhiko Igawa et al. · The Journal of Urology 25 Jan 2010 89
42 KMD-3213, a uroselective and long-acting alpha(1a)-adrenoceptor antagonist, tested in a novel rat model. Katsuyoshi Akiyama, Masachiyo Hora, Satoshi Tatemichi et al. · PubMed Oct 1999 89
43 Which concentration of the inhibitor should be used to predict in vivo drug interactions from in vitro data? Kiyomi Ito, Kōji Chiba, Masato Horikawa et al. · AAPS PharmSci Open access Dec 2002 87
44 Effect of Grinding with Hydroxypropyl Cellulose on the Dissolution and Particle Size of a Poorly Water-Soluble Drug. Tatsuhiko Yamada, Noriyasu Saito, Teruko Imai et al. · Chemical and Pharmaceutical Bulletin Open access 1999 86
45 Sustained-release of protein from biodegradable sericin film, gel and sponge Ayumu Nishida, Masaki Yamada, Takanori Kanazawa et al. · International Journal of Pharmaceutics 15 Jan 2011 86
46 Sodium-glucose cotransporter inhibitors for diabetes. Masayuki Isaji · PubMed Apr 2007 86
47 Evaluation of the repeated-dose liver and gastrointestinal tract micronucleus assays with 22 chemicals using young adult rats: Summary of the collaborative study by the Collaborative Study Group for the Micronucleus Test (CSGMT)/The Japanese Environmental Mutagen Society (JEMS) – Mammalian Mutagenicity Study Group (MMS) Shuichi Hamada et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis Open access 5 Jan 2015 84
48 Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin Fumiki Oana, Hiroo Takeda, Kohichi Hayakawa et al. · Metabolism 28 Jul 2005 83
49 Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model Sachi Tsunemi, Tsuyoshi Iwasaki, Sachie Kitano et al. · Clinical Immunology 26 Apr 2010 83
50 Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice Shigeru Nakano, Kenji Katsuno, Masayuki Isaji et al. · Journal of Clinical and Experimental Hepatology Open access 28 Apr 2015 82

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.